US Stock MarketDetailed Quotes

UNCY Unicycive Therapeutics

Watchlist

0.6889
+0.0110+1.62%

Close Nov 29 13:00 ET

0.6890
+0.0001+0.01%

Post 16:50 ET

71.51MMarket Cap-1497P/E (TTM)

Unicycive Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-109.23%-9.25M

-14.85%-6.32M

-64.69%-6.46M

-16.82%-18.28M

27.04%-4.44M

-24.11%-4.42M

-80.57%-5.5M

-32.57%-3.92M

-171.39%-15.65M

-333.64%-6.08M

Net income from continuing operations

5.47%-4.1M

356.77%9.86M

-43.83%-20.96M

-69.14%-30.54M

-46.36%-7.8M

22.03%-4.33M

-5.56%-3.84M

-312.07%-14.58M

-80.27%-18.06M

-93.60%-5.33M

Operating gains losses

-25.64%-1.75M

-5,860.99%-16.81M

13.81%11.81M

--10.3M

--1.61M

---1.4M

---282K

--10.38M

----

Depreciation and amortization

55.70%123K

-244.87%-113K

531.11%284K

76.40%284K

95.24%82K

97.50%79K

95.00%78K

15.38%45K

1,138.46%161K

223.08%42K

Other non cash items

----

-99.35%21K

----

Change In working capital

-1,481.27%-4.13M

106.73%108K

1,980.22%1.89M

-107.89%-93K

210.33%1.12M

-82.29%299K

-729.02%-1.6M

-63.75%91K

1,221.90%1.18M

-184.11%-1.02M

-Change in prepaid assets

-204.22%-3.39M

132.91%365K

297.63%1.34M

-1,901.61%-1.12M

328.96%767K

-388.16%-1.11M

-406.35%-1.11M

28.52%338K

104.68%62K

-175.79%-335K

-Change in payables and accrued expense

-142.52%-631K

15.84%-372K

525.91%822K

0.71%1.28M

166.61%427K

-24.05%1.48M

-531.43%-442K

-904.17%-193K

2.84%1.27M

-182.39%-641K

-Change in other current liabilities

-56.94%-113K

316.98%115K

-405.56%-273K

-66.89%-252K

-82.50%-73K

-89.47%-72K

-43.24%-53K

-50.00%-54K

-1,158.33%-151K

-233.33%-40K

Cash from discontinued investing activities

Operating cash flow

-109.23%-9.25M

-14.85%-6.32M

-64.69%-6.46M

-16.82%-18.28M

27.04%-4.44M

-24.11%-4.42M

-80.57%-5.5M

-32.57%-3.92M

-171.39%-15.65M

-333.64%-6.08M

Investing cash flow

Cash flow from continuing investing activities

-24K

-66.67%-20K

-6K

-500.00%-12K

-12K

93.10%-2K

Net PPE purchase and sale

---24K

-66.67%-20K

---6K

-500.00%-12K

--0

---12K

--0

93.10%-2K

--0

Cash from discontinued investing activities

Investing cash flow

---24K

-66.67%-20K

---6K

-500.00%-12K

--0

---12K

--0

93.10%-2K

--0

Financing cash flow

Cash flow from continuing financing activities

-205.88%-156K

-811K

64.37%45.69M

5,947.35%27.54M

56.48%-205K

-51K

27.8M

-102.11%-471K

-471K

Net common stock issuance

----

--0

----

-99.95%11K

----

Net preferred stock issuance

--0

65.62%50M

--30.19M

--0

--30.19M

--0

Cash dividends paid

--0

----

--0

----

Net other financing activities

-207.84%-157K

--284K

-80.07%-4.31M

-449.59%-2.65M

---205K

---51K

--0

---2.39M

---482K

----

Cash from discontinued financing activities

Financing cash flow

-207.84%-157K

---811K

64.37%45.69M

5,947.35%27.54M

56.48%-205K

---51K

--0

--27.8M

-102.11%-471K

---471K

Net cash flow

Beginning cash position

122.02%41.78M

101.09%48.93M

2,032.09%9.7M

-97.26%455K

104.64%14.35M

77.98%18.82M

78.65%24.33M

-97.26%455K

--16.58M

-61.08%7.01M

Current changes in cash

-110.89%-9.43M

-29.67%-7.15M

64.30%39.23M

157.34%9.25M

29.15%-4.64M

-25.54%-4.47M

-80.96%-5.51M

906.93%23.88M

-197.26%-16.12M

-357.75%-6.56M

End cash Position

125.49%32.35M

122.02%41.78M

101.09%48.93M

2,032.09%9.7M

104.64%14.35M

77.98%18.82M

78.65%24.33M

-97.26%455K

Free cash flow

-109.77%-9.28M

-14.96%-6.34M

-64.85%-6.46M

-16.88%-18.3M

27.04%-4.44M

-24.11%-4.42M

-80.96%-5.51M

-32.48%-3.92M

-170.07%-15.65M

-324.86%-6.08M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-109.23%-9.25M	-14.85%-6.32M	-64.69%-6.46M	-16.82%-18.28M	27.04%-4.44M	-24.11%-4.42M	-80.57%-5.5M	-32.57%-3.92M	-171.39%-15.65M	-333.64%-6.08M
Net income from continuing operations	5.47%-4.1M	356.77%9.86M	-43.83%-20.96M	-69.14%-30.54M	-46.36%-7.8M	22.03%-4.33M	-5.56%-3.84M	-312.07%-14.58M	-80.27%-18.06M	-93.60%-5.33M
Operating gains losses	-25.64%-1.75M	-5,860.99%-16.81M	13.81%11.81M	--10.3M	--1.61M	---1.4M	---282K	--10.38M	----	----
Depreciation and amortization	55.70%123K	-244.87%-113K	531.11%284K	76.40%284K	95.24%82K	97.50%79K	95.00%78K	15.38%45K	1,138.46%161K	223.08%42K
Other non cash items	----	----	----	----	----	----	----	----	-99.35%21K	----
Change In working capital	-1,481.27%-4.13M	106.73%108K	1,980.22%1.89M	-107.89%-93K	210.33%1.12M	-82.29%299K	-729.02%-1.6M	-63.75%91K	1,221.90%1.18M	-184.11%-1.02M
-Change in prepaid assets	-204.22%-3.39M	132.91%365K	297.63%1.34M	-1,901.61%-1.12M	328.96%767K	-388.16%-1.11M	-406.35%-1.11M	28.52%338K	104.68%62K	-175.79%-335K
-Change in payables and accrued expense	-142.52%-631K	15.84%-372K	525.91%822K	0.71%1.28M	166.61%427K	-24.05%1.48M	-531.43%-442K	-904.17%-193K	2.84%1.27M	-182.39%-641K
-Change in other current liabilities	-56.94%-113K	316.98%115K	-405.56%-273K	-66.89%-252K	-82.50%-73K	-89.47%-72K	-43.24%-53K	-50.00%-54K	-1,158.33%-151K	-233.33%-40K
Cash from discontinued investing activities
Operating cash flow	-109.23%-9.25M	-14.85%-6.32M	-64.69%-6.46M	-16.82%-18.28M	27.04%-4.44M	-24.11%-4.42M	-80.57%-5.5M	-32.57%-3.92M	-171.39%-15.65M	-333.64%-6.08M
Investing cash flow
Cash flow from continuing investing activities	-24K	-66.67%-20K	-6K	-500.00%-12K	0	0	-12K	0	93.10%-2K	0
Net PPE purchase and sale	---24K	-66.67%-20K	---6K	-500.00%-12K	--0	--0	---12K	--0	93.10%-2K	--0
Cash from discontinued investing activities
Investing cash flow	---24K	-66.67%-20K	---6K	-500.00%-12K	--0	--0	---12K	--0	93.10%-2K	--0
Financing cash flow
Cash flow from continuing financing activities	-205.88%-156K	-811K	64.37%45.69M	5,947.35%27.54M	56.48%-205K	-51K	0	27.8M	-102.11%-471K	-471K
Net common stock issuance	----	----	----	--0	----	----	----	----	-99.95%11K	----
Net preferred stock issuance	--0	--0	65.62%50M	--30.19M	--0	--0	--0	--30.19M	--0	--0
Cash dividends paid	--0	----	----	----	----	--0	----	----	----	----
Net other financing activities	-207.84%-157K	--284K	-80.07%-4.31M	-449.59%-2.65M	---205K	---51K	--0	---2.39M	---482K	----
Cash from discontinued financing activities
Financing cash flow	-207.84%-157K	---811K	64.37%45.69M	5,947.35%27.54M	56.48%-205K	---51K	--0	--27.8M	-102.11%-471K	---471K
Net cash flow
Beginning cash position	122.02%41.78M	101.09%48.93M	2,032.09%9.7M	-97.26%455K	104.64%14.35M	77.98%18.82M	78.65%24.33M	-97.26%455K	--16.58M	-61.08%7.01M
Current changes in cash	-110.89%-9.43M	-29.67%-7.15M	64.30%39.23M	157.34%9.25M	29.15%-4.64M	-25.54%-4.47M	-80.96%-5.51M	906.93%23.88M	-197.26%-16.12M	-357.75%-6.56M
End cash Position	125.49%32.35M	122.02%41.78M	101.09%48.93M	2,032.09%9.7M	2,032.09%9.7M	104.64%14.35M	77.98%18.82M	78.65%24.33M	-97.26%455K	-97.26%455K
Free cash flow	-109.77%-9.28M	-14.96%-6.34M	-64.85%-6.46M	-16.88%-18.3M	27.04%-4.44M	-24.11%-4.42M	-80.96%-5.51M	-32.48%-3.92M	-170.07%-15.65M	-324.86%-6.08M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data